Haemonetics Corp. [NYSE: HAE] slipped around -1.45 points on Thursday, while shares priced at $88.64 at the close of the session, down -1.61%.
Compared to the average trading volume of 471.56K shares, HAE reached a trading volume of 2458332 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Haemonetics Corp. [HAE]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HAE shares is $113.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HAE stock is a recommendation set at 1.71. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Mizuho have made an estimate for Haemonetics Corp. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 13, 2022. The new note on the price target was released on January 27, 2022, representing the official price target for Haemonetics Corp. stock. Previously, the target price had yet another drop from $75 to $59, while Citigroup kept a Neutral rating on HAE stock.
The Average True Range (ATR) for Haemonetics Corp. is set at 2.77, with the Price to Sales ratio for HAE stock in the period of the last 12 months amounting to 3.44. The Price to Book ratio for the last quarter was 4.69, with the Price to Cash per share for the same quarter was set at 3.52. Price to Free Cash Flow for HAE in the course of the last twelve months was 39.03 with Quick ratio for the last quarter at 1.50.
How has HAE stock performed recently?
Haemonetics Corp. [HAE] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.50. With this latest performance, HAE shares gained by 2.81% in over the last four-week period, additionally plugging by 7.51% over the last 6 months – not to mention a rise of 7.22% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HAE stock in for the last two-week period is set at 42.23, with the RSI for the last a single of trading hit 32.52, and the three-weeks RSI is set at 47.80 for Haemonetics Corp. [HAE]. The present Moving Average for the last 50 days of trading for this stock 87.31, while it was recorded at 92.58 for the last single week of trading, and 85.15 for the last 200 days.
Haemonetics Corp. [HAE]: Deeper insight into the fundamentals
Haemonetics Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 2.56.
Earnings analysis for Haemonetics Corp. [HAE]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HAE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Haemonetics Corp. go to 12.00%.
Insider trade positions for Haemonetics Corp. [HAE]
The top three institutional holders of HAE stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in HAE stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in HAE stock with ownership which is approximately 5.8386%.
